Healthcare Industry News: ultrasound
News Release - November 7, 2013
Medical Device Executive Joins Kona Medical as Chief Medical OfficerOmar Dawood, M.D., M.P.H., to lead Global Clinical and Regulatory Affairs for the Kona Surround Sound® Renal Denervation System for Treatment of Hypertension
BELLEVUE, Wash. & MENLO PARK, Calif.--(Healthcare Sales & Marketing Network)--Kona Medical announced that medical device executive and clinician Omar Dawood, M.D., M.P.H., has joined the company as Chief Medical Officer, Senior Vice President of Medical Affairs.
Dr. Dawood brings over 20 years of management, medical research and clinical experience to bear in his new role at Kona. He most recently served as Senior Vice President of Global Medical Affairs for Accuray Incorporated. At Accuray, Dr. Dawood spent nearly seven years in public-facing roles leading the global medical affairs and clinical teams, sparking a revolution in the radiation oncology field that opened up new markets based on clinical applications with solid clinical evidence. In his role with Kona Medical, he will lead the global clinical and regulatory efforts supporting the company’s non-invasive Surround Sound® Renal Denervation System. Dr. Dawood’s clinical background in surgery, radiology and interventional radiology provides a deep foundation of imaging and procedural expertise that is ideally suited for Kona’s clinical development.
“Omar brings visionary clinical and regulatory experience to Kona,” said Michael Gertner, M.D., founder and CEO of Kona Medical. “I’ve been following and impressed with Omar’s contributions at Accuray and am excited to have him join our senior management team.”
About Kona Medical
Kona Medical’s Surround Sound® Renal Denervation System utilizes ultrasound, delivered from outside the body, to ablate renal nerves. Kona’s system will afford the opportunity to increase patient access to renal denervation and improve the procedure. The company’s proprietary approach to targeted therapeutic energy delivery is covered by numerous patents and provides a broad platform applicable to a number of clinical applications. Kona is based in Bellevue, Washington, and Menlo Park, California.
For additional information, please visit www.konamedical.com.
Note: Kona Medical’s technology is investigational and is not yet for sale or approved by the U.S. Food and Drug Administration.
Source: Kona Medical
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.